Statistics for Rapid Micro Biosystems, (id:8432 RPID)

Valuation metrics

Market cap

46.44M

Enterprise value

-8,089,224.00

Trailing P/E (ttm)

-0.89

Forward P/E

-1.24

PEG ratio

-1.24

Price/Sales (ttm)

1.77

Price/Book (mrq)

0.57

Enterprise Value/Revenue

-0.31

Enterprise Value/EBITDA

0.17

Overview

Shares outstanding

37.72M

Float

9.31M

Shares short

70.42K

% Held by insiders

0.09%

% Held by institutions

0.58%

Average volume (10 days)

69.80K

Average volume (90 days)

Price summary

52-Week low

0.58

52-Week high

1.34

52-Week change

2.78%

Beta

1.08

50-Day moving average

0.96

200-Day moving average

0.88

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-184.92%

Operating margin

-158.32%

Operational effectiveness

Return on assets

-25.33%

Return on equity

-45.62%

Income statement

Revenue (ttm)

0.60

Revenue per share (ttm)

0.60

Quarterly revenue growth (yoy)

Gross profit (ttm)

-5,485,000.00

EBITDA

-48,600,000.00

Net income to common (ttm)

-48,395,000.00

Diluted EPS (ttm)

-1.12

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

60.83M

Total cash per share (mrq)

1.39

Total debt (mrq)

6.45M

Total Debt/Equity (mrq)

7.65

Current ratio (mrq)

552.30%

Book value per share (mrq)

1.93

Cash flow

Cash flow statement

-44,526,000.00

Levered free cash flow (LFCF)

-52,467,000.00